In CLL, CD38, through its enzymatic activity, regulates NAD metabolism which leads to an increase in cytoplasmic Ca2+ concentrations, positively influencing proliferation and signaling mediated via chemokine receptors or integrins [42]. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.